Evaluating new geriatric care units for older patients undergoing digestive and urological surgeries

Evaluation of the New Peri-Operative Geriatric Units in Ile-de-France, in Digestive and Urological Surgery

Observational Gérond'if · NCT06448494

This study is testing if new care units for older patients having digestive and urological surgeries can help them recover better and avoid complications after their operations.

Quick facts

Study typeObservational
Enrollment1400 (estimated)
Ages75 Years and up
SexAll
SponsorGérond'if Academic / other
Locations1 site (Paris, IIe-de-France)
Trial IDNCT06448494 on ClinicalTrials.gov

What this trial studies

This observational study aims to assess the effectiveness of new Peri-Operative Geriatric Units in managing older patients undergoing specific digestive and urological surgeries. It includes a prospective group of patients scheduled for these surgeries and a retrospective group from 2019 for comparison. The study will document medical follow-up in the 10 days post-operation and patient outcomes over the subsequent 3 months, focusing on complications, rehospitalization, and overall recovery. The goal is to determine if the new geriatric units improve post-operative care and outcomes for elderly patients.

Who should consider this trial

Good fit: Ideal candidates are male or female patients aged 75 years or older scheduled for specific digestive or urological surgical procedures.

Not a fit: Patients who are undergoing other scheduled interventions not included in the study may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could enhance post-operative care and recovery for elderly patients undergoing digestive and urological surgeries.

How similar studies have performed: While this approach is relatively novel, similar studies have shown potential benefits in geriatric care, indicating a promising avenue for improving outcomes.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female subject, aged ≥ 75 years,
* Subject receiving or having received one of the 9 procedures targeted by the study: colectomy, or cholecystectomy, or nephrectomy, or transurethral resection of prostate adenoma, or transurethral prostatectomy, or transurethral or transcutaneous surgery for non-lithiasis conditions, or kidney and ureter surgery and major bladder surgery for tumor disease, or esophageal, stomach and duodenal surgery for malignancy, or transurethral resection of bladder,
* Subject orally agreeing (non-opposition), after having been informed and having been given a reasonable period of reflection, to participate in the study.

Exclusion Criteria:

* Patient having to undergo, at the time the study is proposed and over the theoretical period of participation, one or more other interventions already scheduled (other than the 9 mentioned in the inclusion criteria), and which, in the investigator's opinion, could have an impact on the study indicators7
* Subject unable to understand the purpose of the research, to answer questions and to give his/her decision to participate in the study,
* Subjects under legal protection or unable to express their consent, in accordance with article L1121-8 of the French Public Health Code,
* Subject already included in another research project involving the human body,
* Subject not affiliated to or not benefiting from a social security scheme.

Where this trial is running

Paris, IIe-de-France

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Digestive and Urological SurgeryPeri-operative geriatric unit
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.